Core Viewpoint - Celanese reported quarterly earnings of $0.57 per share, exceeding the Zacks Consensus Estimate of $0.37 per share, but down from $2.08 per share a year ago, indicating a significant earnings surprise of 54.05% [1] Financial Performance - The company posted revenues of $2.39 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 5.49%, although this is a decrease from $2.61 billion in the same quarter last year [2] - Over the last four quarters, Celanese has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Performance - Celanese shares have declined approximately 33.6% since the beginning of the year, contrasting with the S&P 500's decline of -3.3% [3] - The current consensus EPS estimate for the upcoming quarter is $1.43 on revenues of $2.45 billion, and for the current fiscal year, it is $5.13 on revenues of $9.73 billion [7] Industry Outlook - The Chemical - Specialty industry, to which Celanese belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Celanese's stock performance [5]

[Non-US GAAP Financial Measures and Supplemental Information](index=1&type=section&id=Non-US%20GAAP%20Financial%20Measures%20and%20Supplemental%20Information) This report provides supplemental financial information and reconciles non-US GAAP measures to their US GAAP counterparts, offering additional insights into the company's performance [Introduction and Definitions](index=1&type=section&id=Introduction%20and%20Definitions) This section defines key non-GAAP financial measures and explains their importance for assessing the company's performance and internal planning - The company presents its business in two segments: Engineered Materials and the Acetyl Chain[4](index=4&type=chunk) - Management discloses non-GAAP financial measures as supplemental information for investors, believing them to be important for assessing financial results and comparing periods, and should be viewed as supplemental to US GAAP measures[6](index=6&type=chunk) - The report provides definitions for key non-GAAP measures including: Adjusted EBIT, Operating EBITDA, Adjusted Gross Profit, Adjusted Earnings Per Share, Free Cash Flow, Net Debt, and Return on Invested Capital (Adjusted)[9](index=9&type=chunk)[11](index=11&type=chunk)[15](index=15&type=chunk) - The company does not provide forward-looking reconciliations for non-GAAP measures like Adjusted EBIT or Free Cash Flow due to the difficulty in forecasting certain items like mark-to-market pension gains or working capital changes[11](index=11&type=chunk)[12](index=12&type=chunk)[15](index=15&type=chunk) [Financial Performance and Reconciliations](index=6&type=section&id=Financial%20Performance%20and%20Reconciliations) This section presents detailed unaudited financial tables reconciling US GAAP measures to non-GAAP metrics, covering key performance indicators and segment-level data [Table 1: Adjusted EBIT and Operating EBITDA Reconciliation](index=6&type=section&id=Table%201%20Adjusted%20EBIT%20and%20Operating%20EBITDA%20-%20Reconciliation%20of%20Non-GAAP%20Measures%20-%20Unaudited) This table reconciles Net Earnings to Adjusted EBIT and Operating EBITDA, showing Q1 2025 Adjusted EBIT of **$234 million** and Operating EBITDA of **$414 million** Reconciliation of Net Earnings to Adjusted EBIT and Operating EBITDA (In $ millions) | Measure | Q1 '25 | 2024 | Q4 '24 | | :--- | :--- | :--- | :--- | | Net earnings (loss) attributable to Celanese Corporation | (21) | (1,522) | (1,914) | | Certain Items attributable to Celanese Corporation | 43 | 2,009 | 1,696 | | **Adjusted EBIT** | **234** | **1,648** | **333** | | Depreciation and amortization expense | 180 | 728 | 184 | | **Operating EBITDA** | **414** | **2,376** | **517** | [Table 2: Supplemental Segment Data and Reconciliation](index=7&type=section&id=Table%202%20-%20Supplemental%20Segment%20Data%20and%20Reconciliation%20of%20Segment%20Adjusted%20EBIT%20and%20Operating%20EBITDA%20-%20Non-GAAP%20Measures%20-%20Unaudited) This table provides segment-level Adjusted EBIT and Operating EBITDA, with Engineered Materials reporting **$126 million** Adjusted EBIT and Acetyl Chain **$168 million** in Q1 2025 Segment Adjusted EBIT (In $ millions) | Segment | Q1 '25 | 2024 | Q4 '24 | | :--- | :--- | :--- | :--- | | Engineered Materials | 126 | 859 | 156 | | Acetyl Chain | 168 | 1,102 | 253 | | Other Activities | (60) | (313) | (76) | | **Total** | **234** | **1,648** | **333** | Segment Operating EBITDA (In $ millions) | Segment | Q1 '25 | 2024 | Q4 '24 | | :--- | :--- | :--- | :--- | | Engineered Materials | 235 | 1,296 | 270 | | Acetyl Chain | 229 | 1,346 | 316 | | Other Activities | (50) | (266) | (69) | | **Total** | **414** | **2,376** | **517** | [Table 2a: Adjusted Gross Profit Reconciliation](index=9&type=section&id=Table%202a%20Adjusted%20gross%20profit) This table reconciles Gross Profit to Adjusted Gross Profit for the Engineered Materials segment, showing **$1,356 million** Adjusted Gross Profit for 2024 Engineered Materials Adjusted Gross Profit (In $ millions) | Description | 2024 | 2021 | | :--- | :--- | :--- | | Gross profit | 1,236 | 1,670 | | Certain Items | 120 | 27 | | **Adjusted gross profit** | **1,356** | **1,697** | - The **$120 million** in "Certain Items" for 2024 included **$115 million** for exit and shutdown costs and **$3 million** for mergers, acquisitions, and dispositions[23](index=23&type=chunk) [Table 3 & 3a: Adjusted Earnings per Share and Tax Rate Reconciliation](index=10&type=section&id=Table%203%20Adjusted%20Earnings%20(Loss)%20per%20Share%20-%20Reconciliation%20of%20a%20Non-GAAP%20Measure%20-%20Unaudited) These tables reconcile GAAP earnings per share to Adjusted EPS, reporting **$0.57** Adjusted EPS for Q1 2025 and an adjusted effective tax rate of **9%** for 2025 Adjusted Earnings Per Share Reconciliation | Description | Q1 '25 (per share) | 2024 (per share) | Q4 '24 (per share) | | :--- | :--- | :--- | :--- | | Earnings (loss) from continuing operations | (0.15) | (13.86) | (17.45) | | **Adjusted earnings (loss) from continuing operations** | **0.57** | **8.37** | **1.45** | Adjusted Tax Rate Reconciliation (In percentages) | Description | Estimated 2025 | Actual 2024 | | :--- | :--- | :--- | | US GAAP annual effective tax rate | 20 | (51) | | Adjustments | (11) | 60 | | **Adjusted tax rate** | **9** | **9** | [Table 4, 4a, 4b, & 4c: Net Sales Analysis](index=12&type=section&id=Table%204%20Net%20Sales%20by%20Segment%20-%20Unaudited) This section analyzes net sales by segment, with total net sales of **$2,389 million** in Q1 2025, showing a 1% sequential increase and a 9% year-over-year decrease Net Sales by Segment (In $ millions) | Segment | Q1 '25 | 2024 | Q4 '24 | | :--- | :--- | :--- | :--- | | Engineered Materials | 1,287 | 5,607 | 1,281 | | Acetyl Chain | 1,116 | 4,763 | 1,110 | | **Total Net sales** | **2,389** | **10,280** | **2,370** | - Sequential Change (Q1'25 vs Q4'24): Total sales increased **1%**, driven by a **2%** increase in volume, partially offset by a **1%** negative currency impact[29](index=29&type=chunk) - Year-over-Year Change (Q1'25 vs Q1'24): Total sales decreased **9%**, driven by a **5%** decrease in volume and a **3%** decrease in price[34](index=34&type=chunk) - Full Year Change (2024 vs 2023): Total sales decreased **6%**, driven by a **4%** decrease in price and a **1%** decrease in volume[39](index=39&type=chunk) [Table 5: Free Cash Flow Reconciliation](index=16&type=section&id=Table%205%20Free%20Cash%20Flow%20-%20Reconciliation%20of%20a%20Non-GAAP%20Measure%20-%20Unaudited) This table reconciles net cash from operating activities to free cash flow, reporting a negative free cash flow of **($73) million** in Q1 2025 Free Cash Flow Reconciliation (In $ millions) | Description | Q1 '25 | 2024 | Q4 '24 | | :--- | :--- | :--- | :--- | | Net cash provided by (used in) operating activities | 37 | 966 | 494 | | Capital expenditures on property, plant and equipment | (102) | (435) | (105) | | Contributions from/(Distributions) to NCI | (8) | (33) | (8) | | **Free cash flow** | **(73)** | **498** | **381** | [Table 6: Cash Dividends Received](index=17&type=section&id=Table%206%20Cash%20Dividends%20Received%20-%20Unaudited) This table details cash dividends received from equity investments, totaling **$32 million** in Q1 2025 Cash Dividends Received (In $ millions) | Description | Q1 '25 | 2024 | Q4 '24 | | :--- | :--- | :--- | :--- | | Dividends from equity method investments | 31 | 160 | 38 | | Dividends from other equity investments | 1 | 128 | 33 | | **Total** | **32** | **288** | **71** | [Table 7: Net Debt Reconciliation](index=17&type=section&id=Table%207%20Net%20Debt%20-%20Reconciliation%20of%20a%20Non-GAAP%20Measure%20-%20Unaudited) This table reconciles total debt to net debt, showing net debt of **$11,833 million** at the end of Q1 2025 Net Debt Calculation (In $ millions) | Description | Q1 '25 | Q4 '24 | | :--- | :--- | :--- | | Total debt | 12,784 | 12,579 | | Cash and cash equivalents | (951) | (962) | | **Net debt** | **11,833** | **11,617** | [Table 8: Certain Items](index=18&type=section&id=Table%208%20Certain%20Items%20-%20Unaudited) This table details "Certain Items" excluded from non-GAAP measures, totaling **$43 million** in Q1 2025, primarily from exit and shutdown costs Breakdown of Certain Items (In $ millions) | Item | Q1 '25 | 2024 | Q4 '24 | | :--- | :--- | :--- | :--- | | Exit and shutdown costs | 32 | 236 | 47 | | Asset impairments | — | 1,638 | 1,601 | | Mergers, acquisitions and dispositions | 5 | 80 | 12 | | Other Items | 6 | 55 | 36 | | **Total Certain Items** | **43** | **2,009** | **1,696** | - The significant asset impairment in Q4 2024 and full year 2024 was related to goodwill and certain tradenames, primarily Zytel®, arising from impairment tests[45](index=45&type=chunk) [Table 9: Return on Invested Capital (Adjusted)](index=19&type=section&id=Table%209%20Return%20on%20Invested%20Capital%20(Adjusted)%20-%20Presentation%20of%20a%20Non-GAAP%20Measure%20-%20Unaudited) This table calculates the Return on Invested Capital (Adjusted) for 2024, which was **7.8%** based on tax-effected adjusted EBIT Return on Invested Capital (Adjusted) - 2024 | Metric | Value | | :--- | :--- | | Adjusted EBIT tax effected | $1,500 million | | Average Invested capital | $19,265 million | | **Return on invested capital (adjusted)** | **7.8%** | | Net earnings (loss) as a % of invested capital | (7.9)% |

Core Insights - Dunn-Edwards Corporation has partnered with Celanese Corporation to introduce a sustainable pathway for architectural coatings through Carbon Capture and Utilization (CCU) technology, marking a first-to-market initiative in the U.S. [1][2] Group 1: Collaboration and Technology - The collaboration aims to minimize greenhouse gas emissions by utilizing CO2 captured from industrial processes to produce architectural paints [1][2] - Celanese's CCU technology captures industrial CO2 emissions at its Clear Lake, Texas facility, creating a key component for vinyl acetate-based emulsions used in architectural paints [2][3] Group 2: Environmental Impact - The use of CCU resin technology in Dunn-Edwards paints is expected to utilize over 2 million pounds of captured CO2 annually, equivalent to the CO2 consumption of over 800 acres of forest in a year [3] - The initiative aligns with Dunn-Edwards' commitment to sustainability, aiming to provide high-performance products while minimizing environmental impact [4] Group 3: Company Background - Dunn-Edwards is a leading manufacturer and distributor of premium architectural and industrial paints, operating over 170 stores across several states and employing approximately 1,700 people [6] - Celanese Corporation is a global leader in chemistry with a commitment to sustainability, reporting net sales of $10.3 billion in 2024 and employing over 11,000 people worldwide [7]

Core Viewpoint - Celanese has experienced a 4.2% increase in share price since the last earnings report, outperforming the S&P 500, but there are concerns about potential pullbacks leading up to the next earnings release [1]. Estimates Movement - Estimates for Celanese have trended downward over the past month, with a significant consensus estimate shift of -77.68% [2]. VGM Scores - Celanese holds a Growth Score of B, a Momentum Score of F, and a Value Score of C, resulting in an aggregate VGM Score of C, indicating a middle-tier position in investment strategy [3]. Outlook - The downward trend in estimates suggests a negative outlook for Celanese, reflected in its Zacks Rank of 5 (Strong Sell), indicating expectations of below-average returns in the coming months [4].

DALLAS, March 19, 2025 /PRNewswire/ -- Celanese Corporation (NYSE: CE) ("Celanese"), a global chemical and specialty materials company, today announced the pricing of offers by its direct wholly-owned subsidiary Celanese US Holdings LLC (the "Company") to purchase for cash any validly tendered (and not validly withdrawn) and accepted notes in an aggregate principal amount equal to (i) €552,082,000 of 4.777% Senior Notes due 2026 (the "EUR Notes") and (ii) $500,000,000 of 6.415% Senior Notes due 2027 (the "U ...

Core Viewpoint - Celanese Corporation is conducting early tender offers to purchase a total of €552,082,000 of 4.777% Senior Notes due 2026 and $500,000,000 of 6.415% Senior Notes due 2027, with increased Series Caps for both notes [1][2]. Group 1: Tender Offer Details - The tender offers are for cash purchases of validly tendered notes, with the total principal amount of EUR Notes and USD Notes being increased from previously announced amounts [1][2]. - As of the Early Tender Time, €552,082,000 of EUR Notes and $1,354,646,000 of USD Notes were validly tendered and not withdrawn [4]. - The Series Cap for the EUR Notes is set at €552,082,000, while the USD Notes have a Series Cap of $500,000,000 [6][8]. Group 2: Acceptance and Pricing - The Company expects to accept all validly tendered EUR Notes and $500,000,000 of USD Notes, with a pro rata acceptance for the USD Notes based on a proration factor of 36.40% [4][7]. - The Total Consideration for each €1,000 or $1,000 principal amount of Notes will be determined based on fixed spreads and reference yields, including an Early Tender Premium [9]. - Payment for the accepted Notes is expected to occur on March 21, 2025, following the pricing announcement [10]. Group 3: Company Overview - Celanese Corporation is a global leader in chemistry, producing specialty material solutions across major industries, with 2024 net sales reported at $10.3 billion [24].

Celanese Corporation (CE) recently announced that its subsidiary, Celanese US Holdings LLC, has priced registered offerings of $2.6 billion in total principal amount of notes, including $700 million total principal amount of 6.5% Senior Notes due 2030, $1.1 billion total principal amount of 6.75% Senior Notes due 2033 and €750 million (roughly $810 million) total principal amount of 5.000% Senior Notes due 2031. The aggregate principal amount of notes in the offering was increased from $2 billion to $2.6 bi ...

Group 1 - Celanese Corporation (CE) has partnered with Baumit to develop sustainable paint and plaster solutions utilizing carbon capture and utilization (CCU) technology aimed at Baumit's European customers [1][2] - CE's ECO-CC products convert waste emissions into chemical raw materials, capturing CO2 to be used as a raw material in binders, which will be 100% recycled into facade plasters and paints, thereby reducing carbon emissions [2] - This collaboration is expected to reduce Baumit's CO2 emissions by over 5,000 tons annually, aligning with Baumit's GO2morrow sustainability goal and promoting a circular economy [3] Group 2 - CE's stock has experienced a significant decline of 64.2% over the past year, contrasting with a 22% decline in the industry [3] - CE currently holds a Zacks Rank of 5 (Strong Sell), while competitors like Ingevity Corporation (NGVT), Carpenter Technology Corporation (CRS), and ArcelorMittal (MT) have better rankings [4] - Ingevity's current-year earnings estimate is $4.45 per share, with a notable average earnings surprise of 202.9% over the past four quarters [5] - Carpenter Technology's earnings estimate stands at $6.95 per share, with an impressive average earnings surprise of 15.7% and a stock increase of 211.7% in the past year [6] - ArcelorMittal's earnings estimate is $3.72 per share, with a consistent performance of surpassing earnings estimates in three of the last four quarters [7]

DALLAS, March 5, 2025 /PRNewswire/ -- Celanese Corporation (NYSE: CE) ("Celanese"), a global chemical and specialty materials company, today announced that its direct wholly-owned subsidiary Celanese US Holdings LLC (the "Company") has commenced offers to purchase for cash any validly tendered (and not validly withdrawn) and accepted notes in an aggregate principal amount of up to (i) €500,000,000 of 4.777% Senior Notes due 2026 (the "EUR Notes") and (ii) $250,000,000 of 6.415% Senior Notes due 2027 (the "U ...

NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Celanese Corporation ("Celanese" or the "Company") (NYSE: CE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Cleanese and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On November 4, 2024, C ...